Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Sponsors
China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Comply with the diagnostic criteria for general type COVID-19 in the "Diagnosis and Treatment Program for COVID-19"(trial version 6th). (2) Aged >= 18 years. (3) Agree to participate in the trial, and the patient, the legal guardian or the person in charge of the medical institution signed the informed consent through paper signature, electronic signature of mobile phone software, or voice authorization.
Exclusion criteria
Exclusion criteria: (1) Critical patients. (2) Patients who can not guarantee compliance of using TCM during the treatment period, or patients who are difficult to take medicine by oral or nasal route. (3) Patients with severe primary respiratory disease or other pathogenic microbial pneumonia that needs to be identified with COVID-19. (4) Pregnant or parturient women. Patient who have a pregnancy plan or a positive urine pregnancy test. (5) Patients with other systemic malignant diseases such as malignant tumors, mental illnesses, etc., which the researchers consider unsuitable for participation in the trial. (6) Patients who have been allergic or intolerant to taking TCM.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The time to 2019-nCoV RNA negativity in patients; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood routine test outcomes;The rate of critcal aggravation;Blood biochemical test outcomes;The 7-point scale; | — |
Countries
China
Contacts
Public ContactHuang Luqi; Ruan Lianguo
China Academy of Chinese Medical Sciences
Outcome results
None listed